| 000 | 01650 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516180550.0 | ||
| 264 | 0 | _c20140203 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1535-4970 | ||
| 024 | 7 |
_a10.1164/rccm.201212-2318OC _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBusse, William W | |
| 245 | 0 | 0 |
_aRandomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cDec 2013 |
||
| 300 |
_a1294-302 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchi _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Interleukin-17 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHolgate, Stephen | |
| 700 | 1 | _aKerwin, Edward | |
| 700 | 1 | _aChon, Yun | |
| 700 | 1 | _aFeng, Jingyuan | |
| 700 | 1 | _aLin, Joseph | |
| 700 | 1 | _aLin, Shao-Lee | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 188 _gno. 11 _gp. 1294-302 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.201212-2318OC _zAvailable from publisher's website |
| 999 |
_c23239423 _d23239423 |
||